CA2616125A1 - Thymosine .beta.4 oxydee tronquee et derives de celle-ci - Google Patents

Thymosine .beta.4 oxydee tronquee et derives de celle-ci Download PDF

Info

Publication number
CA2616125A1
CA2616125A1 CA002616125A CA2616125A CA2616125A1 CA 2616125 A1 CA2616125 A1 CA 2616125A1 CA 002616125 A CA002616125 A CA 002616125A CA 2616125 A CA2616125 A CA 2616125A CA 2616125 A1 CA2616125 A1 CA 2616125A1
Authority
CA
Canada
Prior art keywords
oxidized
thymosin
disease
truncated
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002616125A
Other languages
English (en)
Inventor
Elizabeth Taylor
Robert Goodenow
John Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRANNUS BIOSCIENCES
Original Assignee
GRANNUS BIOSCIENCES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRANNUS BIOSCIENCES filed Critical GRANNUS BIOSCIENCES
Publication of CA2616125A1 publication Critical patent/CA2616125A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002616125A 2005-07-19 2006-07-19 Thymosine .beta.4 oxydee tronquee et derives de celle-ci Abandoned CA2616125A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70064105P 2005-07-19 2005-07-19
US60/700,641 2005-07-19
PCT/US2006/028323 WO2007012066A2 (fr) 2005-07-19 2006-07-19 Thymosine ?4 oxydee tronquee et derives de celle-ci

Publications (1)

Publication Number Publication Date
CA2616125A1 true CA2616125A1 (fr) 2007-01-25

Family

ID=37669572

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002616125A Abandoned CA2616125A1 (fr) 2005-07-19 2006-07-19 Thymosine .beta.4 oxydee tronquee et derives de celle-ci

Country Status (4)

Country Link
EP (1) EP1913013A2 (fr)
AU (1) AU2006269852A1 (fr)
CA (1) CA2616125A1 (fr)
WO (1) WO2007012066A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514383A (ja) * 2008-03-17 2011-05-06 リジェナークス・バイオファーマスーティカルズ・インコーポレイテッド 改良されたベータチモシンフラグメント
WO2010082177A2 (fr) * 2009-01-16 2010-07-22 Sederma Nouveaux composés, notamment des peptides, compositions comprenant ces derniers et leurs utilisations dans les domaines cosmétique et dermopharmaceutique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806632D0 (en) * 1998-03-28 1998-05-27 Stevenson Robert Peptide factor

Also Published As

Publication number Publication date
EP1913013A2 (fr) 2008-04-23
AU2006269852A1 (en) 2007-01-25
WO2007012066A3 (fr) 2007-06-07
WO2007012066A2 (fr) 2007-01-25

Similar Documents

Publication Publication Date Title
ES2468318T3 (es) FSH recombinante que incluye sialilaci�n en alfa 2,3- y alfa 2,6
KR101207155B1 (ko) 관절염증 치료제 또는 예방제
Offner et al. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis
ES2289778T3 (es) Proteinas de fusion de la region constante de la inmunoglobulina/receptor tgf-beta tipo ii.
US20090317457A1 (en) Anti-inflammatory and wound healing effects of lymphoid thymosin b-4
EP1094833B1 (fr) Thymosine beta 4 oxydee
JP7374527B2 (ja) α１－アンチトリプシン（ＡＡＴ）を発現する遺伝子改変された間葉系幹細胞
EA005005B1 (ru) ГИБРИДНЫЙ ПОЛИПЕПТИД β1α-ИНТЕРФЕРОНА ЧЕЛОВЕКА, ЕГО МУТАНТНЫЕ ФОРМЫ И ПРОИЗВОДНЫЕ И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
EA010200B1 (ru) Рекомбинантные тканезащитные цитокины и кодирующие их нуклеиновые кислоты для защиты, восстановления и усиления чувствительных клеток, тканей и органов
PT1887016E (pt) Fragmentos de gonadotropina coriónica humana (hcg) como imunorregulador
EA007967B1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
JPH10511557A (ja) 血管内皮細胞増殖因子の変種、それらの使用およびそれらの生産法
WO2005094890A1 (fr) Composition pour augmenter la stature
KR20230023059A (ko) 인슐린 저항성에 대한 개선된 펩티드 제약
EA010371B1 (ru) Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов
JP2009073845A (ja) ミエリン会合糖タンパク質（ｍａｇ）およびそのインヒビターを用いた組成物および方法
EP0673384A1 (fr) Polypeptides utiles pour traiter des troubles inflammatoires
JP2013530148A (ja) 組換えヒトｇ−ｃｓｆ二量体およびその神経系疾患の治療における用途
EP3604538A1 (fr) Dérivé d'adrénomédulline à durée d'action longue
CA2616125A1 (fr) Thymosine .beta.4 oxydee tronquee et derives de celle-ci
WO2020180144A1 (fr) Nanocage de ferritine pour la présentation multiple d'un trimère de trail et d'un peptide ciblant le cancer et son utilisation en tant qu'agent anticancéreux
KR20110091720A (ko) Ｃｒｈｒ2 펩티드 작용제 및 이의 용도
US20200000888A1 (en) Compositions and methods of treating root avulsion injury
JPH08511172A (ja) 血管障害の遺伝子治療に用いるためのｄｎａ発現ベクター
US10130687B2 (en) Compositions and methods for the treatment of orthopedic disease or injury

Legal Events

Date Code Title Description
FZDE Discontinued